CA2165618C - Nouveaux ethers d'oximes tricycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent - Google Patents

Nouveaux ethers d'oximes tricycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent Download PDF

Info

Publication number
CA2165618C
CA2165618C CA002165618A CA2165618A CA2165618C CA 2165618 C CA2165618 C CA 2165618C CA 002165618 A CA002165618 A CA 002165618A CA 2165618 A CA2165618 A CA 2165618A CA 2165618 C CA2165618 C CA 2165618C
Authority
CA
Canada
Prior art keywords
formula
optionally substituted
alkyl
compound
pyrrolo
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA002165618A
Other languages
English (en)
French (fr)
Other versions
CA2165618A1 (fr
Inventor
Sylvain Rault
Max Robba
Jean-Charles Lancelot
Herve Prunier
Pierre Renard
Bruno Pfeiffer
Beatrice Guardiola-Lemaitre
Marie-Claire Rettori
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ADIR SARL
Original Assignee
ADIR SARL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ADIR SARL filed Critical ADIR SARL
Publication of CA2165618A1 publication Critical patent/CA2165618A1/fr
Application granted granted Critical
Publication of CA2165618C publication Critical patent/CA2165618C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D495/14—Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Anesthesiology (AREA)
  • Otolaryngology (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Indole Compounds (AREA)
CA002165618A 1994-12-22 1995-12-19 Nouveaux ethers d'oximes tricycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent Expired - Fee Related CA2165618C (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9415431A FR2728571B1 (fr) 1994-12-22 1994-12-22 Nouveaux ethers d'oximes tricycliques, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent
FR94.15431 1994-12-22

Publications (2)

Publication Number Publication Date
CA2165618A1 CA2165618A1 (fr) 1996-06-23
CA2165618C true CA2165618C (fr) 2001-04-10

Family

ID=9470078

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002165618A Expired - Fee Related CA2165618C (fr) 1994-12-22 1995-12-19 Nouveaux ethers d'oximes tricycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Country Status (17)

Country Link
US (1) US5627203A (es)
EP (1) EP0718299B1 (es)
JP (1) JP2937837B2 (es)
CN (2) CN1066449C (es)
AT (1) ATE191483T1 (es)
AU (1) AU693615B2 (es)
CA (1) CA2165618C (es)
DE (1) DE69516100T2 (es)
DK (1) DK0718299T3 (es)
ES (1) ES2147271T3 (es)
FI (1) FI956136A (es)
FR (1) FR2728571B1 (es)
GR (1) GR3033507T3 (es)
NO (1) NO955215L (es)
NZ (1) NZ280734A (es)
PT (1) PT718299E (es)
ZA (1) ZA9510901B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2781482B1 (fr) * 1998-07-27 2001-08-31 Adir Nouveaux derives de 8h-thieno-[2,3-b]pyrrolizine-8-one, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
US7241803B2 (en) * 2002-11-21 2007-07-10 New York Blood Center Compounds for inhibition of HIV infection by blocking HIV entry
DE102008015032A1 (de) * 2008-03-17 2009-09-24 Aicuris Gmbh & Co. Kg Substituierte Pyrazolamide und ihre Verwendung
DE102008015033A1 (de) * 2008-03-17 2009-09-24 Aicuris Gmbh & Co. Kg Substituierte (Pyrazolyl-carbonyl)imidazolidinone und ihre Verwendung
DE102008062878A1 (de) 2008-12-17 2010-06-24 Aicuris Gmbh & Co. Kg Substituierte Furancarboxamide und ihre Verwendung
DE102008062863A1 (de) 2008-12-17 2010-06-24 Aicuris Gmbh & Co. Kg Substituierte (Thiophenyl-carbonyl)imidazolidinone und ihre Verwendung

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE371193B (es) * 1972-03-24 1974-11-11 Kabi Ab
US4308399A (en) * 1977-08-30 1981-12-29 Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara Rt. O-(3-Amino-2-hydroxy-propyl)-amidoxime derivatives, process for the preparation thereof and pharmaceutical compositions containing same
US4134894A (en) * 1978-05-04 1979-01-16 Warner-Lambert Company Pyrrolo[1,2-a]indole compounds
HU180739B (en) * 1979-07-03 1983-04-29 Egyt Gyogyszervegyeszeti Gyar Process for producing basic oxime-ethers
US5128364A (en) * 1991-03-28 1992-07-07 Merck Frosst Canada, Inc. Pyrrolo[1,2-a]indole hydroxylamine derivatives as inhibitors of leukotriene biosynthesis

Also Published As

Publication number Publication date
CA2165618A1 (fr) 1996-06-23
ES2147271T3 (es) 2000-09-01
NO955215D0 (no) 1995-12-21
DE69516100T2 (de) 2000-12-14
JP2937837B2 (ja) 1999-08-23
AU4059395A (en) 1996-06-27
US5627203A (en) 1997-05-06
AU693615B2 (en) 1998-07-02
DE69516100D1 (de) 2000-05-11
GR3033507T3 (en) 2000-09-29
ATE191483T1 (de) 2000-04-15
NZ280734A (en) 1997-09-22
JPH08231554A (ja) 1996-09-10
FR2728571A1 (fr) 1996-06-28
NO955215L (no) 1996-06-24
EP0718299B1 (fr) 2000-04-05
DK0718299T3 (da) 2000-09-04
FI956136A0 (fi) 1995-12-20
ZA9510901B (en) 1996-06-24
CN1066449C (zh) 2001-05-30
EP0718299A1 (fr) 1996-06-26
PT718299E (pt) 2000-07-31
FI956136A (fi) 1996-06-23
CN1261073A (zh) 2000-07-26
FR2728571B1 (fr) 1997-01-31
CN1131155A (zh) 1996-09-18

Similar Documents

Publication Publication Date Title
US5536832A (en) N-acyl-2,3-benzodiazepine derivatives pharmaceutical compositions containing them and process for preparing same
US5302599A (en) Therapeutically useful heterocyclic indole compounds
CA2174033C (fr) Nouveaux composes pyridiniques, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent
DE60023146T2 (de) Kondensierte indolinderivate und deren verwendung als 5ht-,insbesondere 5ht2c, rezeptorliganden
FR2689124A1 (fr) Nouvelles naphtylalkylamines, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.
WO1997000860A1 (fr) Composes agonistes du recepteur cb¿2?
EP0708099B1 (fr) Nouveaux composés amides tricycliques, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent
WO1997000868A1 (fr) Derives de 4-phenylaminothiazole, leur procede de preparation et les compositions pharmaceutiques les contenant
FR2761358A1 (fr) Nouveaux composes de n-aryl piperidine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2655988A1 (fr) Nouveaux derives de la napht-1-yl piperazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
EP0571253B1 (fr) Dérivés du benzimidazole à activité antidiabétique et antiagrégante plaquettaire
US6391891B1 (en) Bicyclic compounds as ligands for 5-HT1 receptors
JPH1171376A (ja) 新規なクロメン化合物、それらの製造方法及びそれらを含む医薬組成物
FR2574793A1 (fr) Composes derives d'indole, compositions pharmaceutiques les contenant et procede pour leur preparation
CA2165618C (fr) Nouveaux ethers d'oximes tricycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
CA2323720C (fr) Nouveaux derives polycycliques azaindoliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
EP0841330B1 (fr) Nouveaux dérivés aminométhyl hétérocycliques, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent
EP1682502A1 (en) Sulfonyltetrahydro-3h-benzo(e)indole-8-amine compounds as 5-hydroxytryptamine-6 ligands
EP0998471B1 (fr) Composes heterocycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
EP0745584B1 (fr) Composés arylalkyl(thio) carboxamides ayant une affinité pour des récepteurs mélatoninergiques, leurs procédés de préparation et les compositions pharmaceutiques qui les contiennent
CA1271193A (en) Diazepinoindoles, their production and pharmaceutical compositions containing them
FR2508457A1 (fr) Pyrrolo(2,1-b)quinazolines et pyrido(2,1-b)quinazolines substituees, leur preparation et leurs utilisations therapeutiques
FR2639944A1 (fr) Nouveaux derives de l'indole, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
EP1106608B1 (fr) Nouveaux dérivés (dihydro)benzoxaziniques et (dihydro)benzothiaziniques substitués, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent
WO2001036428A1 (en) Silylated heterocyclic compounds

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed